Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
Insilico Medicine
MedTech
Insilico Medicine nets $110M for new trials, robotic helpers
Insilico's series E round was led by Hong Kong-based firm Value Partners, and joined by Insilico’s previous investors plus unnamed first-time backers.
Conor Hale
Mar 12, 2025 11:00am
Insilico posts benchmarks from 22 AI-designed drug candidates
Feb 11, 2025 9:00am
Insilico Medicine, Menarini sign second $500M+ cancer drug deal
Jan 10, 2025 9:30am
After phase 2 data, Insilico plots pivotal lung disease trial
Nov 12, 2024 1:34pm
Big pharma, biotech ‘won't necessarily be symbiotic’ in AI: S&P
Oct 2, 2024 11:23am
Insilico launches AI assistant for drafting research papers
Jul 23, 2024 3:00pm